Endeavor

Ramping Up the Immune System to Fight Breast Cancer

Clinical trial led by Moffitt evaluates combination immunotherapy for HER2 positive metastatic disease

Adding Inhibitor to Hormonal Therapy Reduces Risk of Breast Cancer Recurrence

Phase 3 trial results could be practice changing for both men and women

Predicting Response to Herpes Virus in Triple-Negative Breast Cancer Patients

New study identifies genetic biomarkers that correlate with higher response rates

Moffitt Scientists Share Innovative Clinical Research at ASCO

The American Society of Clinical Oncology Annual Meeting attracts more than 40,000

Top 5 Moffitt Research Stories of 2022

Cancer center leads the way in investment, research and FDA approvals

Breakthrough Trial Saw Rare Type of Rectal Cancer Vanish in Every Patient

Twelve patients on immunotherapy drug are now cancer free

Certain Patients with Breast Cancer May Not Need Radiation after Surgery

New results show luminal A breast cancer may benefit from endocrine therapy alone

New Data May Change Approach to Treating Multiple Myeloma, Ewing Sarcoma and Breast Cancer

ASCO studies show benefit to reevaluating current standard of care for these diseases

Studies Highlight Optimizing Therapy in Colon and Breast Cancer

Better targeting treatment approaches can greatly reduce toxicities